| Product NDC: | 0781-3059 |
| Proprietary Name: | Digoxin |
| Non Proprietary Name: | Digoxin |
| Active Ingredient(s): | 250 ug/mL & nbsp; Digoxin |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0781-3059 |
| Labeler Name: | Sandoz Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040481 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030821 |
| Package NDC: | 0781-3059-95 |
| Package Description: | 10 AMPULE in 1 CARTON (0781-3059-95) > 2 mL in 1 AMPULE (0781-3059-72) |
| NDC Code | 0781-3059-95 |
| Proprietary Name | Digoxin |
| Package Description | 10 AMPULE in 1 CARTON (0781-3059-95) > 2 mL in 1 AMPULE (0781-3059-72) |
| Product NDC | 0781-3059 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Digoxin |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL |
| Start Marketing Date | 20030821 |
| Marketing Category Name | ANDA |
| Labeler Name | Sandoz Inc |
| Substance Name | DIGOXIN |
| Strength Number | 250 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Cardiac Glycoside [EPC],Cardiac Glycosides [Chemical/Ingredient] |